(Total Views: 347)
Posted On: 08/27/2019 10:52:34 PM
Post# of 149442
I was referring to leronlimab......couldn’t remember if it was no resistance or negligible levels, so I went with the safe answer. Significantly less than current HAART drugs and not sure how it compares to Maraviroc.
There was a good chart somewhere, I wish CytoDyn would publish on their website or investor slides to compare to other CCR5 inhibitors. The differences are drastic and I don’t think they advertise the safety enough.....efficacy is important, but combined with being extremely safe makes it a game changer.
There was a good chart somewhere, I wish CytoDyn would publish on their website or investor slides to compare to other CCR5 inhibitors. The differences are drastic and I don’t think they advertise the safety enough.....efficacy is important, but combined with being extremely safe makes it a game changer.
(1)
(0)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
Scroll down for more posts ▼
